WO2009087663A3 - Oral controlled release coated tablet - Google Patents

Oral controlled release coated tablet Download PDF

Info

Publication number
WO2009087663A3
WO2009087663A3 PCT/IN2008/000794 IN2008000794W WO2009087663A3 WO 2009087663 A3 WO2009087663 A3 WO 2009087663A3 IN 2008000794 W IN2008000794 W IN 2008000794W WO 2009087663 A3 WO2009087663 A3 WO 2009087663A3
Authority
WO
WIPO (PCT)
Prior art keywords
coated tablet
controlled release
release coated
composition
oral controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2008/000794
Other languages
French (fr)
Other versions
WO2009087663A2 (en
Inventor
Nitin Balchandra Dharmadhikari
Yashoraj Rupsinh Zala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Pharmaceutical Industries Ltd
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of WO2009087663A2 publication Critical patent/WO2009087663A2/en
Publication of WO2009087663A3 publication Critical patent/WO2009087663A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

An oral, controlled release coated tablet having one or more surfaces, the coated tablet comprising: a core comprising a drug composition comprising metoprolol or its pharmaceutically acceptable salt, pH dependent polymer that is soluble in water at a pH below 5 and a copolymer of methacrylic acid and methacrylate and; a composition selected from a swellable composition and a reactive composition located in the immediate vicinity of one or more preselected surfaces and; a coating surrounding the core, wherein the coating is operable to be reliably removed fully from the one or more of the preselected surfaces of the tablet.upon contact with an aqueous environment, but not removed from at least one of the surfaces.
PCT/IN2008/000794 2007-11-30 2008-12-01 Oral controlled release coated tablet Ceased WO2009087663A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2630MU2007 2007-11-30
IN2630/MUM/2007 2007-11-30

Publications (2)

Publication Number Publication Date
WO2009087663A2 WO2009087663A2 (en) 2009-07-16
WO2009087663A3 true WO2009087663A3 (en) 2009-11-26

Family

ID=40853546

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2008/000794 Ceased WO2009087663A2 (en) 2007-11-30 2008-12-01 Oral controlled release coated tablet

Country Status (1)

Country Link
WO (1) WO2009087663A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015287299A1 (en) 2014-07-09 2017-02-02 Sun Pharmaceutical Industries Limited Capsule dosage form of metoprolol succinate
US9700530B2 (en) * 2014-07-09 2017-07-11 Sun Pharmaceutical Industries Limited Capsule dosage form of metoprolol succinate
CN114058257B (en) * 2021-11-17 2022-12-13 美氟新材料科技(常州)有限公司 Non-silicon release coating with excellent aging resistance and antibacterial property and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005039481A2 (en) * 2003-09-19 2005-05-06 Sun Pharmaceutical Industries Limited Oral drug delivery system
WO2007016350A2 (en) * 2005-07-28 2007-02-08 Supernus Pharmaceuticals, Inc. Modified release tablet formulations with enhanced mechanical properties
WO2007036952A2 (en) * 2005-07-01 2007-04-05 Rubicon Research Pvt Ltd. Novel sustained release dosage form
WO2007048233A1 (en) * 2005-10-24 2007-05-03 Orbus Pharma Inc. Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005039481A2 (en) * 2003-09-19 2005-05-06 Sun Pharmaceutical Industries Limited Oral drug delivery system
WO2007036952A2 (en) * 2005-07-01 2007-04-05 Rubicon Research Pvt Ltd. Novel sustained release dosage form
WO2007016350A2 (en) * 2005-07-28 2007-02-08 Supernus Pharmaceuticals, Inc. Modified release tablet formulations with enhanced mechanical properties
WO2007048233A1 (en) * 2005-10-24 2007-05-03 Orbus Pharma Inc. Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist

Also Published As

Publication number Publication date
WO2009087663A2 (en) 2009-07-16

Similar Documents

Publication Publication Date Title
WO2008064163A3 (en) Polymer coated drug-ion exchange resins and methods
WO2007133583A3 (en) Zero-order modified release solid dosage forms
NZ778023A (en) Colonic drug delivery formulation
CO5690538A2 (en) FORMULATIONS OF MULTIPLE PARTICLES OF PANTOPRAZOL
WO2009040811A3 (en) Polymer nanoparticles coated by magnetic metal oxide and uses thereof
MX2009008952A (en) Pellets comprising an active substance matrix resistant to gastric juice.
EP2031049A3 (en) Chemical delivery product and process for making the same
WO2007149539A3 (en) Freeze-thaw method for modifying stent coating
WO2009113703A3 (en) Orally-disintegrating solid preparation
WO2007109057A3 (en) Solid dosage form containing a taste masked active agent
AU2001228653A1 (en) Coated implants
WO2009067862A8 (en) An arsenic trioxide medical elution scaffold
MX2011009669A (en) Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients.
EP2286801A3 (en) Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
WO2010011641A3 (en) Microphasic micro-components and methods for controlling morphology via electrified jetting
WO2009006397A3 (en) Electrode systems and methods comprising a hydrophilic swollen polymer
WO2002024174A3 (en) Sustained release composition containing clarithromycin
PL1879936T3 (en) Aqueous emulsion of alpha-silyl terminated polymers that is stable in storage, production of said emulsion and use of the latter
RU2010153904A (en) Niacin-containing Compositions with Modified Release
WO2009090484A3 (en) Mesalazine tablet
WO2009063916A1 (en) Aqueous film coating solution, film coating granule, and tablet comprising the film coating granule
WO2007015761A3 (en) Medical devices coated with a fast dissolving biocompatible coating
WO2009087663A3 (en) Oral controlled release coated tablet
NO20071315L (en) Pharmaceutical preparation in the form of a tablet containing an active principle for abdominal distention.
WO2007146005A3 (en) Sustained release oxycodone composition with acrylic polymer and metal hydroxide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08869360

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08869360

Country of ref document: EP

Kind code of ref document: A2